The use of aflibercept (Eylea) in the treatment of polypoidal choroidal vasculopathy – case report

Paulina Glasner; Dorota Raczyńska; Leopold Glasner

Full text

3/2015 vol. 117

Case report

The use of aflibercept (Eylea) in the treatment of polypoidal choroidal vasculopathy – case report

Paulina Glasner ¹

,

Dorota Raczyńska ¹

,

Leopold Glasner ¹

Klinika Okulistyki Gdańskiego Uniwersytetu Medycznego

Data publikacji online: 2021/06/01

Article file

8KO_03_2015_GLASNER_ZASTOSOWANIE.pdf

AMA

Glasner P, Raczyńska D, Glasner L. The use of aflibercept (Eylea) in the treatment of polypoidal choroidal vasculopathy – case report. Klinika Oczna / Acta Ophthalmologica Polonica. 2015;117(3):189-192.

APA

Glasner, P., Raczyńska, D., & Glasner, L. (2015). The use of aflibercept (Eylea) in the treatment of polypoidal choroidal vasculopathy – case report. Klinika Oczna / Acta Ophthalmologica Polonica, 117(3), 189-192.

Chicago

Glasner, Paulina, Dorota Raczyńska, and Leopold Glasner. 2015. "The use of aflibercept (Eylea) in the treatment of polypoidal choroidal vasculopathy – case report". Klinika Oczna / Acta Ophthalmologica Polonica 117 (3): 189-192.

Harvard

Glasner, P., Raczyńska, D., and Glasner, L. (2015). The use of aflibercept (Eylea) in the treatment of polypoidal choroidal vasculopathy – case report. Klinika Oczna / Acta Ophthalmologica Polonica, 117(3), pp.189-192.

MLA

Glasner, Paulina et al. "The use of aflibercept (Eylea) in the treatment of polypoidal choroidal vasculopathy – case report." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 117, no. 3, 2015, pp. 189-192.

Vancouver

Glasner P, Raczyńska D, Glasner L. The use of aflibercept (Eylea) in the treatment of polypoidal choroidal vasculopathy – case report. Klinika Oczna / Acta Ophthalmologica Polonica. 2015;117(3):189-192.

SUBMIT YOUR PAPER

Share

Integrated with

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications